The published functional neuroimaging results indicate that the major finding in neuroacanthocytosis (NA) is severe striatal hypometabolism, either with or without atrophy. There is some evidence that the right side is more affected than the left. Cortical abnormalities are either not present or subtle, but if present appear to be particularly located in the frontal cortex. As with NA, an intriguing variety of devastating movement disorders may arise when specific striatal lesions occur. Due to the low prevalence of NA only a few patients have been investigated to date, and further studies are needed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, Sanchez-Pernaute R, de Yebenez JG, Boesiger P, Weindl A, Maguire RP (1996) Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington’s disease. Brain 119:2085–2095.
Antonini A, Leenders KL, Eidelberg D (1998) [11C]raclopride-PET studies of the Huntington’s disease rate of progression: relevance of the trinucleotide repeat length. Ann Neurol 43:253–255.
Bohlega S, Riley W, Powe J, Baynton R, Roberts G (1998) Neuroacanthocytosis and aprebetalipoproteinemia. Neurology 50:1912–1914.
Brooks DJ, Ibanez V, Playford ED, Sawle GV, Leigh PN, Kocen RS, Harding AE, Marsden CD (1991) Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study.Ann Neurol 30:166–171.
Danek A, Uttner I, Vogl T, Tatsch K, Witt TN (1994) Cerebral involvement in McLeod syndrome. Neurology 44:117–120.
Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F, Symmans WA, Oechsner M, Kalckreuth W, Watt JM, Corbett AJ, Hamdalla HHM, Marshall AG, Sutton I, Dotti MT, Malandrini A, Walker RH, Daniels G, Monaco AP (2001) McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 50:755–764.
Dobson-Stone C, Velayos-Baeza A, Filippone LA, Westbury S, Storch A, Erdmann T, Wroe SJ, Leenders KL, Lang AE, Dotti MT, Federico A, Mohiddin SA, Fananapazir L, Daniels G, Danek A, Monaco AP (2004) Chorein detection for the diagnosis of chorea-acanthocytosis. Ann Neurol 56:299–302.
Dubinsky RM, Hallett M, Levey R, Di chiro G (1989) Regional brain glucose metabolism in neuroacanthocytosis. Neurology 39:1253–1255.
Dydak U, Mueller S, Sandor PS, Meier D, Boesiger P, Jung HH (2006) Cerebral metabolic alterations in McLeod syndrome. Eur Neurol 56:17–23.
Hardie RJ, Pullon HW, Harding AE, Owen JS, Pires M, Daniels GL, Imai Y, Misra VP, King RH, Jacobs JM (1991) Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain 114:13–49.
Henkel K, Danek A, Grafman J, Butman J, Kassubek J (2006) Head of the caudate nucleus is most vulnerable in chorea-acanthocytosis: a voxel-based morphometry study. Mov Disord 21:1728–1731.
Hosokawa S, Ichiya Y, Kuwabara Y, Ayabe Z, Mitsuo K, Goto I, Kato M (1987) Positron emission tomography in cases of chorea with different underlying diseases. J Neurol Neurosurg Psychiatry 50:1284–1287.
Jung HH, Hergersberg M, Kneifel S, Alkadhi H, Schiess R, Weigell-Weber M, Daniels G, Kollias S, Hess K (2001) McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings. Ann Neurol 49:384–392.
Jung HH, Hergersberg M, Vogt M, Pahnke J, Treyer V, Röthlisberger B, Kollias SS, Russo D, Frey BM (2003) McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement. Transfusion 43:928–938.
Leenders KL, Frackowiak RS, Quinn N, Marsden CD (1986) Brain energy metabolism and dopaminergic function in Huntington’s disease measured in vivo using positron emission tomography. Mov Disord 1:69–77.
Muller-Vahl KR, Berding G, Emrich HM, Peschel T (2007) Chorea-acanthocytosis in monozygotic twins: clinical findings and neuropathological changes as detected by diffusion tensor imaging, FDG-PET and (123) I-beta-CIT-SPECT. J Neurol Feb 8; [Epub ahead of print].
Nicholl DJ, Sutton I, Dotti MT, Supple SG, Danek A, Lawden M (2004) White matter abnormalities on MRI in neuroacanthocytosis. J Neurol Neurosurg Psychiatry 75:1200–1201.
Oechsner M, Buchert R, Beyer W, Danek A (2001) Reduction of striatal glucose metabolism in McLeod choreoacanthocytosis. J Neurol Neurosurg Psychiatry 70:517–520.
Pavese N, Andrews TC, Brooks DJ, Ho AK, Rosser AE, Barker RA, Robbins TW, Sahakian BJ, Dunnett SB, Piccini P (2003) Progressive striatal and cortical dopamine receptor dysfunction in Huntington’s disease: a PET study. Brain 126:1127–1135.
Saiki S, Hirose G, Sakai K, Matsunari I, Higashi K, Saiki M, Kataoka S, Hori A, Shimazaki K (2004) Chorea-acanthocytosis associated with tourettism. Mov Disord 19:833–836.
Sanchez-Pernaute R, Kunig G, del Barrio Alba A, de Yebenes JG, Vontobel P, Leenders KL (2000) Bradykinesia in early Huntington’s disease. Neurology 54:119–125.
Tanaka M, Hirai S, Kondo S, Sun X, Nakagawa T, Tanaka S, Hayashi K, Okamoto K (1998) Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis: a combined PET and MRI study [see comments]. Mov Disord 13:100–107.
van Oostrom JC, Maguire RP, Verschuuren-Bemelmans CC, Veenma-van der Duin L, Pruim J, Roos RA, Leenders KL (2005) Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease. Neurology 65:941–943.
Weindl A, Kuwert T, Leenders KL, Poremba M, Grafin von Einsiedel H, Antonini A, Herzog H, Scholz D, Feinendegen LE, Conrad B (1993) Increased striatal glucose consumption in Sydenham’s chorea. Mov Disord 8:437–444.
Young AB, Penney JB, Starosta-Rubinstein S, Markel DS, Berent S, Giordani B, Ehrenkaufer R, Jewett D, Hichwa R (1986) PET scan investigations of Huntington’s disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol 20:296–303.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Leenders, K.L., Jung, H.H. (2008). Functional Imaging in Neuroacanthocytosis. In: Walker, R.H., Saiki, S., Danek, A. (eds) Neuroacanthocytosis Syndromes II. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71693-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-540-71693-8_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-71692-1
Online ISBN: 978-3-540-71693-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)